Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRMD | CORMEDIX INC | NASDAQ | Biotechnology | $876.97M | $12.93 | 2.54% | $17.67M | 49.73x | 0.30 | United States | ||
| TGTX | TG THERAPEUTICS INC | NASDAQ | Biotechnology | $4.46B | $28.08 | 1.12% | $97.52M | 68.49x | 1.54 | United States | ||
| CORT | CORCEPT THERAPEUTICS INC | NASDAQ | Biotechnology | $7.56B | $71.75 | -0.35% | $102.16M | 56.94x | 0.26 | United States | ||
| GYRE | GYRE THERAPEUTICS INC | NASDAQ | Biotechnology | $783.99M | $8.14 | -0.97% | $9.86M | 203.50x | 0.25 | United States | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | NASDAQ | Biotechnology | $2.47B | $33.38 | 0.30% | $19.04M | 556.33x | 0.34 | Bermuda | ||
| KRYS | KRYSTAL BIOTECH INC | NASDAQ | Biotechnology | $4.35B | $150.27 | -0.04% | $175.01M | 29.41x | 0.09 | United States | ||
| HALO | HALOZYME THERAPEUTICS INC | NASDAQ | Biotechnology | $7.87B | $67.27 | 2.64% | $791.84M | 15.02x | 5.17 | United States | ||
| ARGX | ARGENX SE | NASDAQ | Biotechnology | $39.91B | $653.83 | 0.21% | $811.30M | 26.13x | 0.18 | Belgium | ||
| RPRX | ROYALTY PHARMA PLC | NASDAQ | Biotechnology | $21.20B | $36.35 | -0.41% | $1.29B | 15.74x | 0.93 | United States | ||
| INVA | INNOVIVA INC | NASDAQ | Biotechnology | $1.32B | $20.92 | 0.19% | $125.47M | 34.30x | 0.87 | United States | ||
| AUPH | AURINIA PHARMACEUTICALS INC | NASDAQ | Biotechnology | $1.62B | $12.27 | 1.49% | $86.50M | 27.89x | 0.50 | Canada | ||
| VCEL | VERICEL CORP | NASDAQ | Biotechnology | $1.83B | $36.28 | 1.43% | $22.06M | 259.14x | 0.42 | United States | ||
| EXEL | EXELIXIS INC | NASDAQ | Biotechnology | $10.31B | $38.31 | -0.42% | $831.10M | 17.82x | 0.32 | United States | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | NASDAQ | Biotechnology | $2.12B | $36.87 | 0.99% | $265.05M | 11.67x | 0.43 | United States | ||
| INCY | INCYTE CORP | NASDAQ | Biotechnology | $16.97B | $86.92 | 0.88% | $1.36B | 19.67x | 0.40 | United States | ||
| ADMA | ADMA BIOLOGICS INC | NASDAQ | Biotechnology | $4.05B | $16.99 | 0.12% | $163.11M | 19.31x | 0.40 | United States | ||
| MNKD | MANNKIND CORP | NASDAQ | Biotechnology | $1.14B | $3.73 | 0.81% | $79.10M | 33.91x | -8.48 | United States | ||
| ATRA | ATARA BIOTHERAPEUTICS INC | NASDAQ | Biotechnology | $86.31M | $12.29 | 4.86% | $24.86M | 16.84x | -2.05 | United States | ||
| MDXG | MIMEDX GROUP INC | NASDAQ | Biotechnology | $1.05B | $7.11 | -0.56% | $54.38M | 32.32x | 0.34 | United States | ||
| TECH | BIO-TECHNE CORP | NASDAQ | Biotechnology | $8.40B | $53.60 | -0.26% | $289.57M | 64.58x | 0.31 | United States | ||
| VCYT | VERACYTE INC | NASDAQ | Biotechnology | $2.37B | $30.22 | 0.60% | $63.03M | 70.28x | 0.10 | United States | ||
| NVO | NOVO NORDISK A S | NYSE | Biotechnology | $234.01B | $52.41 | 2.87% | $24.46B | 13.46x | 1.87 | Denmark | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | NASDAQ | Biotechnology | $11.05B | $57.54 | -0.79% | $934.37M | 16.73x | 0.24 | United States | ||
| NAGE | NIAGEN BIOSCIENCE INC | NASDAQ | Biotechnology | $799.12M | $10.02 | 3.19% | $19.78M | 43.57x | 0.43 | United States | ||
| CPRX | CATALYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | $2.48B | $20.23 | 0.80% | $310.08M | 11.69x | 0.14 | United States | ||
| GMAB | GENMAB A | NASDAQ | Biotechnology | $14.95B | $23.31 | 1.44% | $1.82B | 11.83x | 0.22 | Denmark | ||
| VRTX | VERTEX PHARMACEUTICALS INC | NASDAQ | Biotechnology | $100.71B | $392.79 | 0.64% | $4.59B | 27.82x | 0.40 | United States |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.